輸入代號或公司名稱後按 Enter
6242

立康

0.00 (0.00%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
34.001成交張數14.17本益比1.28股價淨值比5.88%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.78-3.7%2.410.2515.2%2.85%9.12%
2026Q10.33-37.7%2.440.118.7%1.21%8.86%
2025Q40.887.3%2.640.2816.2%3.24%9.71%
2025Q30.42-22.2%2.580.1311.3%1.60%9.81%
2025Q20.8119.1%2.700.2615.7%3.03%10.44%
2025Q10.5320.4%2.570.1712.5%1.96%9.36%
2024Q40.82-35.9%2.480.2615.9%3.09%10.37%
2024Q30.54-20.8%2.940.1713.4%2.08%11.45%
2024Q20.68-41.8%3.080.2114.2%2.55%12.06%
2024Q10.44-56.4%3.570.1310.2%1.67%13.02%
2023Q41.28-1.1%4.140.3118.1%5.03%18.50%
2023Q30.68-40.0%4.150.1915.1%3.22%20.35%
2023Q21.177.7%4.610.3318.7%5.58%23.74%
2023Q11.01101.7%4.520.2818.1%4.83%22.90%
2022Q41.2966.1%4.020.3618.5%6.51%21.11%
2022Q31.14332.6%3.500.3217.0%6.07%19.28%
2022Q21.09143.8%2.630.3015.1%6.02%15.09%
2022Q10.5040.0%1.990.1413.8%2.79%10.78%
2021Q40.78-30.5%1.840.2216.2%4.48%10.28%
2021Q30.26-71.3%2.190.0711.9%1.56%12.87%
2021Q20.4555.6%2.840.1212.6%2.51%17.22%
2021Q10.36125.0%2.680.1010.7%1.95%14.88%
2020Q41.1239.6%2.480.3119.0%6.38%13.97%
2020Q30.91125.4%2.160.2516.2%5.46%12.89%
2020Q20.29-61.3%1.650.0812.4%1.73%10.26%
2020Q10.16-74.7%2.110.046.3%0.89%12.12%
2019Q40.808.6%2.580.2316.4%4.79%15.16%
2019Q30.41-12.1%2.510.1111.3%2.45%15.43%
2019Q20.74-12.3%2.570.2115.9%4.45%16.21%
2019Q10.63-11.2%2.670.1715.1%3.67%15.69%
2018Q40.74-31.6%2.750.2116.8%4.50%16.82%
2018Q30.46-79.7%3.090.1311.9%2.90%20.04%
2018Q20.84-7.0%4.910.2414.8%5.28%34.90%
2018Q10.7134.8%4.970.2018.6%4.32%33.83%
2017Q41.0828.3%4.790.3021.0%7.01%34.01%
2017Q32.27608.5%4.550.6458.5%16.55%34.68%
2017Q20.9133.2%2.590.2518.1%7.20%21.96%
2017Q10.5246.5%2.370.1514.1%4.19%20.46%
2016Q40.842.200.2417.7%7.14%
2016Q30.320.099.4%2.86%